Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delong Liu

Showing results (21-30 of 287) with videos related to

Pageof 29
Sort By:
Journal of Hematology & Oncology|July 30, 2017
Syk inhibitors in clinical development for hematological malignanciesDelong Liu, Aleksandra Mamorska-Dyga
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery|August 13, 2009
[Investigation of reoperation after failure of UPPP]Qing feng Zhang, Delong Liu
Stem Cell Investigation|July 1, 2016
A new Stem Cell InvestigationZhizhuang Joe Zhao, Delong Liu
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery|September 24, 2009
[Coblation for benign hyperplasia of tongue base under endoscope]Qing feng Zhang, Delong Liu
Journal of Hematology & Oncology|April 14, 2016
Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancerShuhang Wang, Shundong Cang, Delong Liu
Biomarker Research|April 24, 2019
Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphomaAmandeep Aujla, Ravijot Aujla, Delong Liu
Biomarker Research|September 19, 2019
Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemiaJuanjuan Zhao, Yongping Song, Delong Liu
Journal of Hematology & Oncology|November 27, 2010
First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinibGuoqing Wei, Shamudheen Rafiyath, Delong Liu
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 16, 2010
T-cryptantigen (TCA) activation in sever pneumonia complicated with multiple organ failureQiushi Wang, Delong Liu, Yingzhe Bai
Experimental Hematology & Oncology|December 6, 2012
CD19: a biomarker for B cell development, lymphoma diagnosis and therapyKemeng Wang, Guoqing Wei, Delong Liu
Pageof 29

Showing results (21-30 of 287) with videos related to

Sort By:
Pageof 29
Journal of Hematology & Oncology|July 30, 2017
Syk inhibitors in clinical development for hematological malignanciesDelong Liu, Aleksandra Mamorska-Dyga
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery|August 13, 2009
[Investigation of reoperation after failure of UPPP]Qing feng Zhang, Delong Liu
Stem Cell Investigation|July 1, 2016
A new Stem Cell InvestigationZhizhuang Joe Zhao, Delong Liu
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery|September 24, 2009
[Coblation for benign hyperplasia of tongue base under endoscope]Qing feng Zhang, Delong Liu
Journal of Hematology & Oncology|April 14, 2016
Third-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancerShuhang Wang, Shundong Cang, Delong Liu
Biomarker Research|April 24, 2019
Inotuzumab ozogamicin in clinical development for acute lymphoblastic leukemia and non-Hodgkin lymphomaAmandeep Aujla, Ravijot Aujla, Delong Liu
Biomarker Research|September 19, 2019
Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemiaJuanjuan Zhao, Yongping Song, Delong Liu
Journal of Hematology & Oncology|November 27, 2010
First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinibGuoqing Wei, Shamudheen Rafiyath, Delong Liu
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 16, 2010
T-cryptantigen (TCA) activation in sever pneumonia complicated with multiple organ failureQiushi Wang, Delong Liu, Yingzhe Bai
Experimental Hematology & Oncology|December 6, 2012
CD19: a biomarker for B cell development, lymphoma diagnosis and therapyKemeng Wang, Guoqing Wei, Delong Liu
Pageof 29